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Context 
Mothers with big babies tend to have longer labours and more difficult births.  They may require 
caesarean section, or instrumental vaginal delivery. They may also sustain perineal injury or more 
seriously the head may deliver and the shoulders get stuck, so called shoulder dystocia.  This severe 
complication may cause birth injury, including brachial plexus injury (2-16%) which may be 
permanent and disabling. Finally the baby may suffer bony fractures or birth asphyxia with risk of 
neurological damage or death.  Obstetricians have wondered whether inducing labour early might 
make birth easier and reduce injury, but have been cautious to implement this policy due to 
concerns that induced labour may be longer or increase caesareans, and because the diagnosis of 
macrosomia, even using ultrasound scan is notoriously inaccurate.   
Methods  
This is a systematic review of randomised controlled trials of induction of labour at term for 
suspected fetal macrosomia.  Suspected fetal macrosomia was defined as an ultrasonic estimated 
fetal weight > 4000g or ≥ 95th centile.  The primary outcome was caesarean delivery.  RCTs looking 
exclusively at a population of women with pre-existing or gestational diabetes were excluded, but 
RCTs with some women with those conditions were included. 
Findings  
There was no significant effect on Caesarean delivery [relative risk (RR) 0.91, 95% confidence interval 
(CI), 0.76–1.09], operative delivery, shoulder dystocia, intracranial haemorrhage, brachial plexus 
palsy, low Apgar score, cord blood pH <7, or mean birth weight.  The lack of effect on Caesarean 
section accords with other randomised trial of induction near term (1, 2). 
The main benefit from induction was reduced fetal fractures (RR 0.17, 95% CI0.03–0.79). There were 
some harms from induction, hyperbilirubinemia (8.8% versus 2.9%; RR 3.03, 95% CI 1.60–5.74) and 
phototherapy (11.0% versus 6.6%; RR 1.68, 95% CI 1.07–2.66). 
Commentary  
This systematic review from BJOG is timely because in 2015 a large randomised trial, (DAME) (3) of 
822 participants was published but was too small to draw firm conclusions.  This systematic review 
includes the same trials, and draws similar conclusion to the updated Cochrane review on the same 
topic (4).  The Cochrane review calculates the number needed to treat (NNT) to prevent one fracture 
as 60. 
Although Magro-Malosso do not comment on it, there appeared to also be an adverse effect of 
perineal injury.  In the largest study, third- and fourth-degree perineal tears were increased in the 
induction group (RR 3.70, 95% CI 1.04 - 13.17).  There is also a concern from observational studies that 
induction at early term gestations (37-38 weeks) may increase the risk of longer term developmental 
harm (5, 6).  Emerging evidence shows that gestational age may be best conceptualised as a 
continuum in which the risk of adverse neurodevelopmental outcomes increases with each decreasing 
week of gestation at birth, from 40 weeks gestation. Thus induction even as late as 39 weeks may have 
previously unforeseen impact on development.  
Implications for practice  
Unsurprisingly reviewers’ interpretation of these data vary. Magro-Malosso concluded “induction of 
labour ≥38 weeks for suspected fetal macrosomia is associated with a significant decrease in fetal 
fractures, and therefore can be considered as a reasonable option.”  
The Cochrane review was more cautious concluding “although some parents and doctors may feel 
the evidence already justifies induction, others may justifiably disagree. Further trials of induction 
shortly before term for suspected fetal macrosomia are needed. Such trials should concentrate on 
refining the optimum gestation of induction, and improving the accuracy of the diagnosis of 
macrosomia.” 
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